1. Home
  2. GNFT vs CTGO Comparison

GNFT vs CTGO Comparison

Compare GNFT & CTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • CTGO
  • Stock Information
  • Founded
  • GNFT 1999
  • CTGO 2009
  • Country
  • GNFT France
  • CTGO United States
  • Employees
  • GNFT N/A
  • CTGO N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • CTGO Precious Metals
  • Sector
  • GNFT Health Care
  • CTGO Basic Materials
  • Exchange
  • GNFT Nasdaq
  • CTGO Nasdaq
  • Market Cap
  • GNFT 189.6M
  • CTGO 255.7M
  • IPO Year
  • GNFT 2019
  • CTGO N/A
  • Fundamental
  • Price
  • GNFT $3.80
  • CTGO $10.54
  • Analyst Decision
  • GNFT Strong Buy
  • CTGO Strong Buy
  • Analyst Count
  • GNFT 1
  • CTGO 1
  • Target Price
  • GNFT $13.00
  • CTGO $37.00
  • AVG Volume (30 Days)
  • GNFT 9.8K
  • CTGO 174.5K
  • Earning Date
  • GNFT 09-19-2024
  • CTGO 02-12-2025
  • Dividend Yield
  • GNFT N/A
  • CTGO N/A
  • EPS Growth
  • GNFT N/A
  • CTGO N/A
  • EPS
  • GNFT 0.47
  • CTGO N/A
  • Revenue
  • GNFT $86,225,222.00
  • CTGO N/A
  • Revenue This Year
  • GNFT $155.44
  • CTGO N/A
  • Revenue Next Year
  • GNFT N/A
  • CTGO $122.34
  • P/E Ratio
  • GNFT $7.53
  • CTGO N/A
  • Revenue Growth
  • GNFT 175.45
  • CTGO N/A
  • 52 Week Low
  • GNFT $3.31
  • CTGO $10.10
  • 52 Week High
  • GNFT $6.42
  • CTGO $25.32
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 29.24
  • CTGO 23.96
  • Support Level
  • GNFT $3.63
  • CTGO $11.36
  • Resistance Level
  • GNFT $3.88
  • CTGO $12.06
  • Average True Range (ATR)
  • GNFT 0.10
  • CTGO 0.84
  • MACD
  • GNFT 0.02
  • CTGO -0.03
  • Stochastic Oscillator
  • GNFT 15.30
  • CTGO 12.83

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About CTGO Contango ORE Inc.

Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's primary focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Tetlin Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska.

Share on Social Networks: